Decoupling Lineage-Associated Genes in Acute Myeloid Leukemia Reveals Inflammatory and Metabolic Signatures Associated With Outcomes
暂无分享,去创建一个
Chenyue W. Hu | M. Konopleva | A. Qutub | Linghua Wang | Jianhua Zhang | A. Futreal | N. Daver | S. Kornblau | Y. Qiu | V. Mohanty | Ken Chen | Shaoheng Liang | Yuefan Huang | C. Bolen | Ruiping Wang | H. Abbas | Feng Wang | Monique Dail
[1] M. Minden,et al. Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia , 2019, Science Translational Medicine.
[2] J. Budczies,et al. Elevated HOX gene expression in acute myeloid leukemia is associated with NPM1 mutations and poor survival , 2019, Journal of advanced research.
[3] C. Simillion,et al. CD8+ T cells expand stem and progenitor cells in favorable but not adverse risk acute myeloid leukemia , 2019, Leukemia.
[4] Chenyue W. Hu,et al. A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia , 2019, Nature Biomedical Engineering.
[5] J. Orange,et al. Myeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype , 2019, Leukemia & lymphoma.
[6] Dirk Mossmann,et al. mTOR signalling and cellular metabolism are mutual determinants in cancer , 2018, Nature Reviews Cancer.
[7] Yassen Assenov,et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer , 2018, Genome research.
[8] E. Olejniczak,et al. A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia. , 2018, Cancer discovery.
[9] Haocai Chang,et al. Downregulation of MCL-1 and upregulation of PUMA using mTOR inhibitors enhance antitumor efficacy of BH3 mimetics in triple-negative breast cancer , 2018, Cell Death & Disease.
[10] Bob Löwenberg,et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. , 2017, Blood.
[11] Inigo Martincorena,et al. Precision oncology for acute myeloid leukemia using a knowledge bank approach , 2017, Nature Genetics.
[12] K. Coombes,et al. MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cells , 2016, Oncotarget.
[13] Alex M. Fichtenholtz,et al. Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting. , 2016, Blood.
[14] Andrew D. Rouillard,et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..
[15] Joshua A. Bittker,et al. Correlating chemical sensitivity and basal gene expression reveals mechanism of action , 2015, Nature chemical biology.
[16] J. Mesirov,et al. The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .
[17] E. Eklund,et al. HoxA10 Terminates Emergency Granulopoiesis by Increasing Expression of Triad1 , 2015, The Journal of Immunology.
[18] Peng Qiu,et al. Single‐cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3‐ITD‐mutated AML stem/progenitor cells , 2015, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[19] Daniel J Weisdorf,et al. Acute Myeloid Leukemia. , 2015, The New England journal of medicine.
[20] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[21] Alex M. Fichtenholtz,et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing , 2013, Nature Biotechnology.
[22] Benjamin J. Raphael,et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.
[23] E. Chen,et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.
[24] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[25] Justin Guinney,et al. GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.
[26] J. Tamburini,et al. The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia , 2012, Leukemia.
[27] Chris Williams,et al. RNA-SeQC: RNA-seq metrics for quality control and process optimization , 2012, Bioinform..
[28] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[29] K. Baggerly,et al. Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment. , 2010, Blood.
[30] K. Baggerly,et al. Targeting of mTORC 1 / 2 by the mTOR kinase inhibitor PP 242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment , 2012 .
[31] B. Viollet,et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 , 2011, Nature Cell Biology.
[32] Mingming Jia,et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..
[33] Jiang Li,et al. mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cells , 2010, Molecular Cancer.
[34] Chang Hwa Jung,et al. mTOR regulation of autophagy , 2010, FEBS letters.
[35] G. Pejler,et al. Canine Uterine Bacterial Infection Induces Upregulation of Proteolysis-Related Genes and Downregulation of Homeobox and Zinc Finger Factors , 2009, PloS one.
[36] Ben S. Wittner,et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 , 2009, Nature.
[37] H. Taylor,et al. Thrombin and interleukin-1beta decrease HOX gene expression in human first trimester decidual cells: implications for pregnancy loss. , 2009, Molecular human reproduction.
[38] Peter J. Woolf,et al. GAGE: generally applicable gene set enrichment for pathway analysis , 2009, BMC Bioinformatics.
[39] Steve Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[40] K. Coombes,et al. HOX expression patterns identify a common signature for favorable AML , 2008, Leukemia.
[41] David M Sabatini,et al. Defining the role of mTOR in cancer. , 2007, Cancer cell.
[42] T. Golub,et al. Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. , 2006, Cancer cell.
[43] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[44] R. Tibshirani,et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. , 2004, The New England journal of medicine.
[45] R. Verhaak,et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. , 2004, The New England journal of medicine.
[46] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[47] J. Downing,et al. Acute myeloid leukemia. , 1999, The New England journal of medicine.
[48] Z. Estrov,et al. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax. , 1996, Blood.